Gladstone Institutes Senior investigator, Professor Katerina Akassoglou explains how this damage could be happening. (Full Article)
“Even patients who are asymptomatic or they have very mild infection symptoms can still develop neurological symptoms,” said Katerina Akassoglou, PhD, UCSF Prof. at Dept. Neurology & Senior Investigator t the Gladstone Institutes.
Illustration by Ella Marushchenko
The Akassoglou Lab showed toxic blood leaks in the brain inhibiting remyelination with implications for the development of therapeutic strategies for neuro-repair in multiple sclerosis and other neurological diseases with blood-brain barrier disruption and myelin damage. From Petersen et al. BMP receptor blockade overcomes extrinsic inhibition of remyelination and restores neurovascular homeostasis. Pp. 2291-2301.
A small team of scientists at the Akassoglou Lab is working on what could be a big breakthrough in treating dementia and other brain diseases. To read full article , click here.
Katerina Akassoglou will lead the new Gladstone-UCSF Center for Neurovascular Brain Immunology, which brings together a unique combination of expertise to enable novel therapies for Alzheimer Alzheimer’s disease and multiple sclerosis. To read full article, click here.
February 5, 2019
Gladstone scientists Katerina Akassoglou and Mario Merlini found that a blood protein destroys memory storage sites in the brain and may lead to new treatments.
Click Here to read full article
October 31, 2019
Click here to read full article.
Jorge Palop (left) and Katerina Akassoglou (right) received an NIH grant to study the link between neurovascular dysfunction and cognitive decline in Alzheimer’s disease.
